India’s Pharma GCCs Cut Drug Timelines by 1–2 Years, Lower R&D Costs: KPMG Report
Hyderabad, Feb 18 (TNT): India’s Pharma and Life Sciences Global Capability Centres (GCCs) are cutting drug development timelines by one to two years and reducing R&D-to-launch costs by nearly five percentage points, according to a joint report released by KPMG in India and UnearthIQ […….]
